EDN1 and idiopathic pulmonary arterial hypertension: Lipophilic statins inhibited ET-1 release in a concentration-dependent manner from PASMCs isolated from patients with IPAH (Figure 6A), and these inhibitory effects were reversed by the addition of MVA or GGPP, but not FPP (Figure 6B).